Form 10-Q · Quarterly report
Veralto 10-Q, filed Oct 30, 2026
- Filed
- CIK
- 0001967680
- Accession no.
- 0001967680-26-000048
Summary
Veralto filed its quarterly report on Form 10-Q for the three- and nine-month periods ended October 2, 2026, with a management discussion and analysis covering forward-looking statements and the company's material risk factors. Among the risks management cites are global economic conditions, U.S. and retaliatory tariffs and trade restrictions, intense competition, uncertainty around the development and use of artificial intelligence, and the impact of acquisitions, divestitures and restructuring.
Key points
- Veralto's Form 10-Q covers the three- and nine-month periods ended October 2, 2026.
- Management's discussion is organized into forward-looking statements, overview, results of operations, liquidity and capital resources, and critical accounting estimates.
- The company lists tariffs and trade restrictions, competition, AI development and deployment, cybersecurity, restructuring and tax law changes among the risks that could affect results.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide material information relevant to an assessment of the Company’s financial condition and results of operations, including an evaluation of the amounts and certainty of cash flows from operations and from outside sources. The MD&A is designed to focus specifically on material events and uncertainties known to management that are reasonably likely to cause reported financial information not to be necessarily indicative of future operating results or of future financial condition. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.